A Comparison between CHEK2*1100delC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis

Publisher： Karger

E-ISSN： 1423-0232|90|4|193-198

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.4, 2016-03, pp. : 193-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative analysis of GATA3 mutation profiles between Asian and Western patients with breast cancer: Is there really a difference?

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2778-2779

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to comparative analysis of GATA3 mutation profiles between Asian and Western patients with breast cancer: Is there really a difference?

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2779-2780

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene −842(G > C) and −667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters

By Naidu Rakesh   Har Yip C.   Taib Nur A. M.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 6, 2011-10 ,pp. : 500-506

Informa Healthcare

Access to resources Recommend Favorite

Analysis of Clinicopathological Characteristics and Prognosis of 1425 Primary Breast Cancer Patients in Eastern Guangdong, China

By  

Current Signal Transduction Therapy, Vol. 9, Iss. 1, 2014-04 ,pp. : 44-49

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor‐2‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 844-853

John Wiley & Sons Inc

Access to resources Recommend Favorite